RESEARCH TRIANGLE PARK, N.C., June 10, 2024--As cancer incidence continues to rise, it’s being met by wider use of innovative therapies and a robust pipeline of new drugs, according to a new report from the IQVIA Institute for Human Data Science titled, "Global Oncology Trends 2024: Outlook to 2028."
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Key Insights IQVIA Holdings' estimated fair value is US$325 based on 2 Stage Free Cash Flow to Equity IQVIA Holdings is...